Krasimira Rozenova
she/her/hers
Assistant ProfessorAbout
Titles
Assistant Professor
Biography
Dr. Krasimira Rozenova, MD, PhD, is an Assistant Professor of Anatomic Pathology at Yale University, specializing in hematopathology and molecular diagnostic pathology. Dr. Rozenova earned her PhD from the University of Kentucky, focusing on cell signaling and inflammation, and obtained her medical degree from St. George's University. She completed her residency in anatomic and clinical pathology at the Mayo Clinic, followed by fellowship training in hematopathology at Memorial Sloan Kettering Cancer Center (MSKCC) and in molecular genetic pathology at Yale. Dr. Rozenova’s primary research interests include lymphoma and the application of short tandem repeat (STR) testing in pathology for both diagnostic and quality assurance purposes. She has presented her work at national and international meetings and co-authored multiple manuscripts in her field. At Yale, Dr. Rozenova is deeply involved in clinical responsibilities, teaching, and mentorship, actively contributing to the education of pathology residents and fellows.
Appointments
Pathology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Molecular Genetic Pathology Fellow
- Yale School of Medicine (2024)
- Hematopathology Fellow
- Memorial Sloan KetteringCancer Center (2023)
- Residency
- Mayo Clinic (2022)
- MD
- St George's University, Medicine (2018)
- Post-Doctoral Fellowship
- Children's Hospital of Philadelphia (2014)
- PhD
- University of Kentucky, Physiology (2009)
- MSc
- Sofia University, Biochemistry (2001)
- BSc
- Sofia University, Molecular Biology (1999)
Advanced Training & Certifications
- Young Physician's Leadership Curriculum
- Yale University (2024)
Research
Research at a Glance
Publications Timeline
A big-picture view of Krasimira Rozenova's research output by year.
20Publications
49Citations
Publications
2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.
Rozenova K, Willrich M, Snyder M, Dasari S, Kourelis T, Rajkumar SV, Kumar S, Dispenzieri A, Murray DL. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance. J Appl Lab Med 2023, 8: 742-750. PMID: 37232112, DOI: 10.1093/jalm/jfad027.Peer-Reviewed Original ResearchPrimary thymic marginal zone lymphoma with amyloidosis.
Rozenova KA, Xiao W. Primary thymic marginal zone lymphoma with amyloidosis. Blood 2023, 141: 1494. PMID: 36951878, DOI: 10.1182/blood.2022019001.Peer-Reviewed Case Reports and Technical NotesDedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab
Rozenova KA, et al. Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab, Human Pathology Reports, Volume 31, 2023, 300688, ISSN2772-736XPeer-Reviewed Case Reports and Technical Notes
2022
Utilization of skin biopsy for diagnosis in a case of Lafora disease.
Rozenova KA, Lehman JS, Grande JP, Fine AL, Wieland CN. Utilization of skin biopsy for diagnosis in a case of Lafora disease. J Cutan Pathol 2022, 49: 885-888. PMID: 35708461, DOI: 10.1111/cup.14275.Peer-Reviewed Case Reports and Technical NotesNonhealing Ulcer at a Surgical Site.
Rozenova KA, Bridges AG. Nonhealing Ulcer at a Surgical Site. Mayo Clin Proc 2022, 97: 325-326. PMID: 35120694, DOI: 10.1016/j.mayocp.2021.11.031.Peer-Reviewed Case Reports and Technical Notes
2021
CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
Rozenova KA, Jevremovic D, Reichard KK, Nguyen P, Otteson GE, Timm MM, Horna P, Olteanu H, Shi M. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases. Hum Pathol 2021, 114: 66-73. PMID: 34019867, DOI: 10.1016/j.humpath.2021.05.007.Peer-Reviewed Original ResearchUncommon Cause of Emesis and Diarrhea in a Nonverbal Elderly Patient.
Rozenova K, Pritt BS, Said S. Uncommon Cause of Emesis and Diarrhea in a Nonverbal Elderly Patient. Gastroenterology 2021, 160: e5-e7. PMID: 32946898, DOI: 10.1053/j.gastro.2020.09.012.Peer-Reviewed Case Reports and Technical NotesMedication-induced Pseudo-Pelger-Huet Anomaly and severe neutropenia
Rozenova, K.A., Shi M. Medication-induced Pseudo-Pelger-Huet Anomaly and severe neutropenia. J Hematopathol 14, 257-259 (2021), https://doi.org/10.1007/s12308-021-00457-5Peer-Reviewed Case Reports and Technical Notes
2020
A Rare Case of Pembrolizumab-Associated Granulomatous Panniculitis.
Rozenova KA, Bridges AG. A Rare Case of Pembrolizumab-Associated Granulomatous Panniculitis. Mayo Clin Proc 2020, 95: 2315-2316. PMID: 33153618, DOI: 10.1016/j.mayocp.2020.08.037.Peer-Reviewed Case Reports and Technical Notes
2019
The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.
Donaghy R, Han X, Rozenova K, Lv K, Jiang Q, Doepner M, Greenberg RA, Tong W. The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination. Blood 2019, 133: 1560-1571. PMID: 30755420, DOI: 10.1182/blood-2018-10-877563.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity Association for Molecular Pathology
Professional OrganizationsMemberDetailsMember05/01/2021 - Presentactivity ASCP
Professional OrganizationsMemberDetailsmember07/01/2019 - 07/01/2024activity A 64-year-old man with systemic mastocytosis with an associated mixed-phenotype acute myeloid leukemia (Mye/T)
Oral PresentationXVI European bone marrow working groupDetails04/13/2023 - 04/15/2023Barcelona, CT, SpainSponsored by MSKCCCollaboratorsactivity Multidimentional deep T-cell phenotyping defines immune response in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
Oral PresentationUSCAP 112th annual meetingDetails03/11/2023 - 03/16/2023New Orleans, LA, United StatesSponsored by MSKCCCollaboratorsactivity CAP
Professional OrganizationsCommittee MemberDetailsJunior member appointment Council on Scientific Affairs2022 - 2022
Get In Touch
Contacts
Locations
BML35
Academic Office
Brady Memorial Laboratory
310 Cedar Street
New Haven, CT 06510
Events
Jun 202514-16Multiple Days
Everyone Multi-session EventPei Hui, PhD, MD - Krasimira Rozenova - Natalia Buza, MD - Deyin Xing, MD, PhD